Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study record itself remains behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T13:14:30.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T13:17:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.1 instead of v3.7.0. The study page still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-10T13:08:42.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study details, indicating an access restriction. The surrounding header and footer remain visible but the study content is not accessible.
    Difference
    20%
    Check dated 2026-09-19T19:40:11.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The NIH funding reference '2018 ( U.S. NIH Grant/Contract )' was added to the study identifiers, and the page revision was updated to v3.6.6 (replacing v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T20:17:41.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, reflecting a minor page update. No substantive study content or data appear to be changed.
    Difference
    0.0%
    Check dated 2026-08-08T19:58:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.